Irinotecan News and Research

RSS
Irinotecan hydrochloride is approved by the Food and Drug Administration (FDA) to be used with other drugs to treat colorectal cancer that has metastasized (spread to other parts of the body). It is also approved to treat metastatic colorectal cancer that has recurred (come back) or gotten worse after earlier chemotherapy. In addition to the uses that have been approved by the FDA, irinotecan hydrochloride is sometimes used to treat other types of cancer. Irinotecan hydrochloride is also being studied in the treatment of other types of cancer.
Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

New cancer drug Avastin keeps cancer under control

New cancer drug Avastin keeps cancer under control

Avastin available across Europe within the next few weeks

Avastin available across Europe within the next few weeks

Avastin plus Folfox4 chemotherapy significantly extends survival in second-line metastatic colorectal cancer

Avastin plus Folfox4 chemotherapy significantly extends survival in second-line metastatic colorectal cancer

Acne-like rash linked to effectiveness of new targeted cancer treatment – cetuximab

Acne-like rash linked to effectiveness of new targeted cancer treatment – cetuximab

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Drug helps patients with metastatic colorectal cancer

Drug helps patients with metastatic colorectal cancer

Drug to extend lives of colorectal cancer patients

Drug to extend lives of colorectal cancer patients

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer